Which has the lower trailing P/E, BMY or SNY?

BMY has the lower trailing P/E: BMY trades at 14.90 and SNY at 79.88. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or SNY?

Over the past five years, SNY grew revenue faster — BMY at a 2.08% CAGR versus SNY at 4.96%.

Does BMY or SNY pay a bigger dividend?

BMY yields 3.71% and SNY yields 5.44% based on trailing dividends and the latest price.

Is BMY or SNY more profitable?

BMY runs the higher net margin — BMY at 18.87% versus SNY at 8.10%.

Bristol-Myers Squibb Company (BMY) vs Sanofi (SNY)

A side-by-side comparison of Bristol-Myers Squibb Company and Sanofi across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$138.25B

$67.68HealthcareDelayed quote: Sep 3, 2026, 3:25 PM EDT

SNY

Sanofi

$106.30B

$44.27HealthcareDelayed quote: Sep 3, 2026, 3:25 PM EDT

Total return — BMY vs SNY

growth of $100 · dividends reinvested · last 10y

BMY +68.2% (+5.3%/yr)SNY +70.8% (+5.5%/yr)SNY compounded faster over this window

BMY SNY

BMY vs SNY: by the numbers

•BMY is the larger company ($138.25B vs $106.30B market cap).
•BMY trades at the lower trailing earnings multiple (14.90 vs 79.88 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 8.10% net margin).
•SNY grew revenue faster over the past five years (4.96% vs 2.08% CAGR).
•SNY pays the higher dividend yield (5.44% vs 3.71%).

Metrics side by side

Valuation

Metric	BMY	SNY
P/E ratio	14.90	79.88
Forward P/E	9.76	N/A
P/S ratio	2.82	1.87
P/B ratio	6.21	1.35
EV / EBITDA	10.21	10.10
FCF yield	8.26%	12.84%

Profitability

Metric	BMY	SNY
Gross margin	70.16%	73.01%
Operating margin	28.27%	14.74%
Net margin	18.87%	8.10%
ROE	41.59%	5.82%
ROIC	15.47%	5.42%

Dividends

Metric	BMY	SNY
Dividend yield	3.71%	5.44%
Payout ratio	72.54%	64.36%

Growth (annualized)

Metric	BMY	SNY
Revenue CAGR (5Y)	2.08%	4.96%
EPS CAGR (5Y)	9.38%	-8.92%
FCF CAGR (5Y)	-0.95%	12.83%
Total return CAGR (5Y)	4.66%	0.92%

Frequently asked

Which has the lower trailing P/E, BMY or SNY?: BMY has the lower trailing P/E: BMY trades at 14.90 and SNY at 79.88. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or SNY?: Over the past five years, SNY grew revenue faster — BMY at a 2.08% CAGR versus SNY at 4.96%.
Does BMY or SNY pay a bigger dividend?: BMY yields 3.71% and SNY yields 5.44% based on trailing dividends and the latest price.
Is BMY or SNY more profitable?: BMY runs the higher net margin — BMY at 18.87% versus SNY at 8.10%.

Go deeper

Full BMY analysis Full SNY analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Sanofi P/E ratio Bristol-Myers Squibb dividend yield Sanofi dividend yield Bristol-Myers Squibb ROE Sanofi ROE Bristol-Myers Squibb operating margin Sanofi operating margin Bristol-Myers Squibb revenue growth Sanofi revenue growth Bristol-Myers Squibb free cash flow Sanofi free cash flow

Bristol-Myers Squibb & Sanofi appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.